Company Filing History:
2 out of 2,943 
1 out of 5 
1 out of 1,743 
Years Active: 2010-2013
Title: The Innovations of Marc Lecomte
Introduction
Marc Lecomte is a notable inventor based in Lissieu, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of diabetic retinopathy. With a total of 3 patents to his name, his work focuses on innovative compounds and methods that address critical health issues.
Latest Patents
Lecomte's latest patents include groundbreaking inventions such as specific caspase-10 inhibitors. This invention relates to compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, i, and j have the meanings given in the claim. These compounds are particularly useful as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy. Another significant patent involves methods of treating diabetic retinopathy with pericyte apoptosis inhibitors. This method discloses a way to prevent or treat diabetic retinopathy by administering a therapeutically effective amount of an inhibitor of retinal pericyte apoptosis. Additionally, it includes a pharmaceutical composition that treats and/or prevents diabetic retinopathy, comprising a therapeutically effective amount of at least one inhibitor of retinal pericyte apoptosis and a pharmaceutically acceptable carrier.
Career Highlights
Throughout his career, Marc Lecomte has worked with prominent companies such as Merck Patent GmbH and Merck Santé. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Lecomte has collaborated with esteemed colleagues, including Claude Lardy and Catherine Vidal. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical field.
Conclusion
Marc Lecomte's contributions to the field of pharmaceutical sciences, particularly in the treatment of diabetic retinopathy, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing medical science through research and development.